Browse > Article

In Vitro Antiviral Activity of Aqueous Extracts from Korean Medicinal Plants Against Influenza Virus Type A  

Park, Kap-Joo (Department of Biological Sciences, Konkuk University)
Lee, Hyung-Hoan (Department of Biological Sciences, Konkuk University)
Publication Information
Journal of Microbiology and Biotechnology / v.15, no.5, 2005 , pp. 924-929 More about this Journal
Abstract
Boiled-water extracts from 101 Korean medicinal plants were tested in vitro for their inhibitory activity against influenza virus type A by means of a modified hemagglutination inhibition test. Thirteen of the 101 extracts exhibited strong anti-influenza virus type A activity at concentrations of less than $780\;{\mu}g/ml$. Out of the above 13 extracts, MW-40 (Chaenomeles speciosa), MW-88 (Citrus junos), and MW-100 (Zingiber officinale) exhibited marked antiviral activity in the concentration range of $0.195\;{\mu}g/ml$ to 100 mg/ml, $0.0487\;{\mu}g/ml$ to 100 mg/ml, and $0.0487\;{\mu}g/ml$ to 100 mg/ml, respectively. The extracts MW-88 and MW-100 were not cytotoxic to red blood cells, whereas MW-40 showed very weak cytotoxicity in the concentration range of 50 mg/ml to 100 mg/ml. Therefore, the present results demonstrate that boiled water extracts of 2 Korean medicinal plants, MW-88 and MW-100, have strong anti-influenza virus type A activity and no cytotoxic effects, and they may inhibit attachment of the virus to the cell and may be used for prophylaxis.
Keywords
Influenza virus; hemagglutination inhibition test; Korean medicinal plants; boiled water extracts;
Citations & Related Records

Times Cited By Web Of Science : 7  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Bae, E. A., N. Y. Kim, M. J. Han, M. K. Choo, and D. H. Kim. 2003. Transformation of ginsenosides to compound K (IH-901) by lactic acid bacteria of human intestine. J. Microbiol. Biotechnol. 13: 9-14
2 Boivin, G. and N. Goyette. 2002. Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors. Antiviral Res. 54: 143 -147   DOI   ScienceOn
3 Laver, W. G. 1973. The polypeptides of influenza viruses. Adv. Virus Res. 18: 57-103   DOI
4 Yoon, K. Y. 1992. Clinical Prescriptions of Korean Traditional Medical Books. Myung Bo Publishing. Seoul
5 Perry, E. K., A. T. Pickering, W. W. Wang, P. J. Houghton, and N. S. Perry. 1999. Medicinal plants and Alzheimer's disease: From ethnobotany to phytotherapy. J. Pharm. Pharmacol. 51: 527-534   DOI
6 Shaw, M. W., N. H. Arden, and H. F. Maassab. 1992. New aspects of influenza viruses. Clin. Microbiol. Rev. 1: 74-92
7 Kent, I. H., L. E. Chapman, L. M. Schmelts, H. L. Regnery, N. J. Cox, and A. Schonberger. 1991-1992. Influenza surveillance-United States. Mor. Mortal. Wky. Rep. 41: 35-46
8 Shin J. H., K. H. Kim, T. H. Kim, J. M. Lee, and H. J. Lee. 2003. Effects of growth regulators and organic nitrogen sources on the production of heavy chain immunoglobulin G in suspension culture of transgenic tobacco cells. J. Microbiol. Biotechnol. 13: 256-262
9 Brock, T. D., M. T. Madigan, J. M. Marrtinko, and I. Parker. 1997. Biology of microorganisms. In: Influenza Virus, 7th Ed. Prentice-Hall, Upper Saddle River, NJ
10 Schulze, I. T. 1973. Structure of the influenza virion. Adv. Virus Res. 18: 1-55   DOI
11 Jeon, Y. H., S. P. Chang, I. G. Hwang, and Y. H. Kim. 2003. Involvement of growth-promoting rhizobacterium Paenibacillus polymyxa in root rot of stored Korean ginseng. J. Microbiol. Biotechnol. 13: 881-891
12 Lee, H. S. 2003. Inhibitory effects of quinizarin isolated from Cassia tora seeds against human intestinal bacteria and aflatoxin B, biotransformation. J. Microbiol. Biotechnol. 13: 529-536
13 Huh, J. 1981. Young-In Bon. Dong Eu Bo Gam. Hang-Sung Book Press. Seoul (Korean Traditional Medicine Book)
14 Lee, S. K. and H. K. Cho. 1985. Effects of saponin of ginseng on the formation of lipid of Rhodotorula glutinis. Kor. J. Appl. Microbiol. Biotecnol. 13: 109-114
15 Ikeda, S. J., J. Neyts, S. Verma, A. W. Wickramasinghe, P. Mohan, and E. de Clerca. 1994. In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion. Antimicrob. Agents Chemother. 38: 256-259   DOI   ScienceOn
16 McLaren, L. C. 1992. Clinical virology manual. In Specter, S. et al. (eds.), Hemagglutination Inhibition and Hemadsorption. Elsevier Science Publishing. New York, U.S.A
17 Klenk, H. D. and L. Rott. 1988. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34: 247-281   DOI